Irinotecan combined with leucovorin-5-fluorouracil in the treatment of advanced colorectal cancer.

被引：0
|
作者：
Rigatos, SK [1 ]
Stathopoulos, GP [1 ]
Nacos, A [1 ]
Stathopoulos, J [1 ]
Pergantas, N [1 ]
Athanassiadis, I [1 ]
机构：
[1] Univ Athens, Dept Oncol, Hippokrat Hosp, Med Div 2, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
246
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [41] Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer
    Douillard, JY
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 51 - 55
  • [42] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [43] Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer -: A feasibility pilot study
    Calvo, E
    Cortés, J
    González-Cao, M
    Rodríguez, J
    Aramendía, JM
    Fernández-Hidalgo, O
    Martín-Algarra, S
    Salgado, JE
    Martínez-Monge, R
    de Irala, J
    Brugarolas, A
    ONCOLOGY, 2002, 63 (03) : 254 - 265
  • [44] Weekly irinotecan and leucovorin and 5-fluorouracil (AIO schedule) in pretreated patients with advanced colorectal cancer: Preliminary results.
    Vardakis, N
    Souglakos, J
    Kalbakis, K
    Agelaki, S
    Mavroudis, D
    Kakolyris, S
    Vamvakas, L
    Palis, A
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2000, 11 : 57 - 57
  • [45] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [46] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [47] A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
    Chen, Emerson Y.
    Blanke, Charles D.
    Haller, Daniel G.
    Benson, Al B.
    Dragovich, Tomislav
    Lenz, Heinz-Josef
    Robles, Carlos
    Li, Hong
    Mori, Motomi
    Mattek, Nora
    Sanborn, Rachel E.
    Lopez, Charles D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (12): : 1193 - 1198
  • [48] Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
    Seium, Y
    Stupp, R
    Ruhstaller, T
    Gervaz, P
    Mentha, G
    Philippe, M
    Allal, A
    Trembleau, C
    Bauer, J
    Morant, R
    Roth, AD
    ANNALS OF ONCOLOGY, 2005, 16 (05) : 762 - 766
  • [49] Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer
    Miaris, Nikolaos
    Sgouros, Joseph
    Gerolympou, Margarita
    Spyropoulos, Basilios
    Drakopoulos, Dionysios
    Gkoura, Stefania
    Res, Helen
    Samantas, Epaminondas
    JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (01) : 123 - 126
  • [50] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
12345